Literature DB >> 20739495

Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period.

Naomi Runnegar1, Hanna Sidjabat, H M Sharon Goh, Graeme R Nimmo, Mark A Schembri, David L Paterson.   

Abstract

Multidrug-resistant Acinetobacter baumannii is a worldwide nosocomial menace. We sought to better understand its behavior through studying the molecular epidemiology of this organism at the Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia, over a 10-year period. Multilocus sequence typing (MLST), semiautomated repetitive sequence-based PCR (rep-PCR), and pulsed-field gel electrophoresis (PFGE) were performed on a selection of 31 A. baumannii isolates collected over the 10-year period to determine their relationships to one another. MLST also allowed us to put this information in a global context. The presence or absence of bla(OXA-23) was also established. The presence of bla(OXA-23) closely correlated with carbapenem resistance in our collection. Sequence type 92 (ST92) was the dominant sequence type and was present in the hospital for 9 years. There was also evidence of the spread of ST69, ST73, and ST125 (novel) within the hospital, but this was not sustained over long periods. There were only single examples of the novel sequence types ST126 and ST127. The different typing methods clustered the isolates similarly; however, PFGE and rep-PCR were more discriminatory than MLST. Worldwide, ST92 and the associated clonal complex 92 represent the most sampled and widespread sequence type(s) and are also known as European clone 2 and worldwide clonal lineage 2. Antibiotic susceptibility within ST92 is variable, suggesting a role for mechanisms other than antibiotic resistance in its success.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739495      PMCID: PMC3020849          DOI: 10.1128/JCM.01208-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Clustal W and Clustal X version 2.0.

Authors:  M A Larkin; G Blackshields; N P Brown; R Chenna; P A McGettigan; H McWilliam; F Valentin; I M Wallace; A Wilm; R Lopez; J D Thompson; T J Gibson; D G Higgins
Journal:  Bioinformatics       Date:  2007-09-10       Impact factor: 6.937

2.  Global spread of carbapenem-resistant Acinetobacter baumannii.

Authors:  Paul G Higgins; Cathrin Dammhayn; Meredith Hackel; Harald Seifert
Journal:  J Antimicrob Chemother       Date:  2009-12-08       Impact factor: 5.790

3.  Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii.

Authors:  Jennifer K Mak; Mi-Jurng Kim; Jeanette Pham; John Tapsall; Peter A White
Journal:  J Antimicrob Chemother       Date:  2008-11-06       Impact factor: 5.790

4.  Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals.

Authors:  Young Kyoung Park; Ji Young Choi; Sook-In Jung; Kyong-Hwa Park; Hyuck Lee; Dong Sik Jung; Sang Taek Heo; Shin-Woo Kim; Hyun-Ha Chang; Hae Suk Cheong; Doo Ryeon Chung; Kyong Ran Peck; Jae-Hoon Song; Kwan Soo Ko
Journal:  Diagn Microbiol Infect Dis       Date:  2009-08       Impact factor: 2.803

5.  Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.

Authors:  Alexandr Nemec; Lenka Krízová; Martina Maixnerová; Laure Diancourt; Tanny J K van der Reijden; Sylvain Brisse; Peterhans van den Broek; Lenie Dijkshoorn
Journal:  J Antimicrob Chemother       Date:  2008-05-13       Impact factor: 5.790

Review 6.  Management of meningitis due to antibiotic-resistant Acinetobacter species.

Authors:  Baek-Nam Kim; Anton Y Peleg; Thomas P Lodise; Jeffrey Lipman; Jian Li; Roger Nation; David L Paterson
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

7.  Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea.

Authors:  Young Kyoung Park; Sook-In Jung; Kyong-Hwa Park; Hae Suk Cheong; Kyong Ran Peck; Jae-Hoon Song; Kwan Soo Ko
Journal:  Diagn Microbiol Infect Dis       Date:  2009-05       Impact factor: 2.803

8.  Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.

Authors:  Jennifer M Adams-Haduch; David L Paterson; Hanna E Sidjabat; Anthony W Pasculle; Brian A Potoski; Carlene A Muto; Lee H Harrison; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

9.  Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme.

Authors:  H Wisplinghoff; C Hippler; S G Bartual; C Haefs; D Stefanik; P G Higgins; H Seifert
Journal:  Clin Microbiol Infect       Date:  2008-07       Impact factor: 8.067

10.  Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii.

Authors:  Pauline D Mugnier; Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more
  29 in total

1.  Epidemiology and resistance features of Acinetobacter baumannii isolates from the ward environment and patients in the burn ICU of a Chinese hospital.

Authors:  Yali Gong; Xiaodong Shen; Guangtao Huang; Cheng Zhang; Xiaoqiang Luo; Supeng Yin; Jing Wang; Fuquan Hu; Yizhi Peng; Ming Li
Journal:  J Microbiol       Date:  2016-08-02       Impact factor: 3.422

2.  Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States.

Authors:  Jennifer M Adams-Haduch; Ezenwa O Onuoha; Tatiana Bogdanovich; Guo-Bao Tian; Jonas Marschall; Carl M Urban; Brad J Spellberg; Diane Rhee; Diane C Halstead; Anthony W Pasculle; Yohei Doi
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

3.  Molecular analysis of the Acinetobacter baumannii biofilm-associated protein.

Authors:  H M Sharon Goh; Scott A Beatson; Makrina Totsika; Danilo G Moriel; Minh-Duy Phan; Jan Szubert; Naomi Runnegar; Hanna E Sidjabat; David L Paterson; Graeme R Nimmo; Jeffrey Lipman; Mark A Schembri
Journal:  Appl Environ Microbiol       Date:  2013-08-16       Impact factor: 4.792

4.  A conjugative plasmid carrying the carbapenem resistance gene blaOXA-23 in AbaR4 in an extensively resistant GC1 Acinetobacter baumannii isolate.

Authors:  Mohammad Hamidian; Johanna J Kenyon; Kathryn E Holt; Derek Pickard; Ruth M Hall
Journal:  J Antimicrob Chemother       Date:  2014-06-06       Impact factor: 5.790

5.  Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii.

Authors:  Evan S Snitkin; Adrian M Zelazny; Clemente I Montero; Frida Stock; Lilia Mijares; Patrick R Murray; Julie A Segre
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

6.  Molecular epidemiology of Acinetobacter baumannii bloodstream isolates obtained in the United States from 1995 to 2004 using rep-PCR and multilocus sequence typing.

Authors:  Paul G Higgins; Katharina Janssen; Maximilian M Fresen; Hilmar Wisplinghoff; Harald Seifert
Journal:  J Clin Microbiol       Date:  2012-08-15       Impact factor: 5.948

7.  Use of adherence monitors as part of a team approach to control clonal spread of multidrug-resistant Acinetobacter baumannii in a research hospital.

Authors:  Tara N Palmore; Angela V Michelin; Maryann Bordner; Robin T Odom; Frida Stock; Ninet Sinaii; Daniel P Fedorko; Patrick R Murray; David K Henderson
Journal:  Infect Control Hosp Epidemiol       Date:  2011-10-26       Impact factor: 3.254

8.  A case of IMP-4-, OXA-421-, OXA-96-, and CARB-2-producing Acinetobacter pittii sequence type 119 in Australia.

Authors:  Witchuda Kamolvit; Petra Derrington; David L Paterson; Hanna E Sidjabat
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

9.  Extended-spectrum AmpC cephalosporinase in Acinetobacter baumannii: ADC-56 confers resistance to cefepime.

Authors:  Guo-Bao Tian; Jennifer M Adams-Haduch; Magdalena Taracila; Robert A Bonomo; Hong-Ning Wang; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

10.  Clonal spread of carbapenem resistant Acinetobacter baumannii ST92 in a Chinese Hospital during a 6-year period.

Authors:  Lei Huang; Liying Sun; Yan Yan
Journal:  J Microbiol       Date:  2013-03-02       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.